Código QR

METformin for the MINimization of Geographic Atrophy Progression (METforMIN): A Randomized Trial

Purpose: Metformin use has been associated with a decreased risk of age-related macular degeneration (AMD) progression in observational studies. We aimed to evaluate the efficacy of oral metformin for slowing geographic atrophy (GA) progression. Design: Parallel-group, multicenter, randomized phase...

ver descrição completa

Na minha lista:
Principais autores: Liangbo Linus Shen, MD, Jeremy D. Keenan, MD, MPH, Noor Chahal, BS, Abu Tahir Taha, BS, Jasmeet Saroya, BS, Chu Jian Ma, MD, Mengyuan Sun, PhD, Daphne Yang, BS, Catherine Psaras, BA, Jacquelyn Callander, MD, Christina Flaxel, MD, Amani A. Fawzi, MD, Thomas K. Schlesinger, MD, PhD, Robert W. Wong, MD, Loh-Shan Bryan Leung, MD, Alexander M. Eaton, MD, Nathan C. Steinle, MD, David G. Telander, MD, Armin R. Afshar, MD, Melissa D. Neuwelt, MD, Jennifer I. Lim, MD, Glenn C. Yiu, MD, PhD, Jay M. Stewart, MD
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2024-05-01
Colecção:Ophthalmology Science
Assuntos:
Age-related macular degeneration
Geographic atrophy
Metformin
Randomized controlled trial
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2666914523001720
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados